Liquid Biopsy Assays For ctDNA Detection

In recent years, liquid biopsies have rapidly evolved and have had a dramatic impact on the field of clinical oncology. Most importantly, their non-invasive nature enables clinicians to isolate, continuously monitor and analyze genetic material circulating around the body including circulating tumor DNA (ctDNA), without any additional complications for the patient. For translational scientists, assays which enable sensitive and accurate detection of patient ctDNA can accelerate the progression of targeted therapies into the clinic and ensure the best treatment decisions are made for patients.